A5084190731- Vaccine Coverage and Hesitancy
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
- Reproductive tract infections research
- HIV, Drug Use, Sexual Risk
- Hepatitis B Virus Studies
- Hepatitis C virus research
- Syphilis Diagnosis and Treatment
- Adolescent Sexual and Reproductive Health
- Bacterial Infections and Vaccines
- Sex work and related issues
- Bacillus and Francisella bacterial research
- Viral Infections and Immunology Research
- Peripheral Neuropathies and Disorders
- Sexuality, Behavior, and Technology
- Liver Disease Diagnosis and Treatment
- Poxvirus research and outbreaks
- Hepatitis Viruses Studies and Epidemiology
- Herpesvirus Infections and Treatments
- Environmental Justice and Health Disparities
- SARS-CoV-2 detection and testing
- HIV-related health complications and treatments
- Liver Disease and Transplantation
- Virology and Viral Diseases
- Reproductive Health and Contraception
Centers for Disease Control and Prevention
2016-2025
The Centers
2024
Community Link
2024
National Center for Emerging and Zoonotic Infectious Diseases
2023
Centers for Disease Control and Prevention
2021-2023
Government of the United States of America
2023
Hepatitis B Foundation
2021
Center for Surveillance, Epidemiology, and Laboratory Services
2021
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
2016-2019
CDC Foundation
2019
As of July 30, 2021, among the three COVID-19 vaccines authorized for use in United States, only Pfizer-BioNTech BNT162b2 mRNA vaccine is adolescents aged 12-17 years. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) persons ≥16 years on December 11, 2020 (1); EUA was expanded to include 12-15 May 10, 2021 (2), based results from a Phase 3 clinical trial (3). Beginning June cases myocarditis myopericarditis (hereafter, myocarditis) after receipt began be...
Importance As self-collected home antigen tests become widely available, a better understanding of their performance during the course SARS-CoV-2 infection is needed. Objective To evaluate diagnostic compared with reverse transcription–polymerase chain reaction (RT-PCR) and viral culture by days from illness onset, as well user acceptability. Design, Setting, Participants This prospective cohort study was conducted January to May 2021 in San Diego County, California, metropolitan Denver,...
School closures affected more than 55 million students across the United States when implemented as a strategy to prevent transmission of SARS-CoV-2, virus that causes COVID-19 (1). Reopening schools requires balancing risks for SARS-CoV-2 infection and staff members against benefits in-person learning (2). During December 3, 2020-January 31, 2021, CDC investigated in 20 elementary (kindergarten through grade 6) had reopened Salt Lake County, Utah. The 7-day cumulative number new cases...
Because of historical associations between vaccines and Guillain-Barré syndrome (GBS), the condition was a prespecified adverse event special interest for COVID-19 vaccine monitoring.To evaluate GBS reports to Vaccine Adverse Event Reporting System (VAERS) compare reporting patterns within 21 42 days after vaccination with Ad26.COV2.S (Janssen), BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna) vaccines.This retrospective cohort study conducted using US VAERS submitted during December 2020...
Background: Vaccination, screening, and linkage to care can reduce the burden of chronic hepatitis B virus (HBV) infection. However, recommendations vary among organizations, their implementation has been suboptimal. The American College Physicians' High Value Care Task Force Centers for Disease Control Prevention developed this article present best practice statements vaccination, care. Methods: A narrative literature review clinical guidelines, systematic reviews, randomized trials,...
Limited postauthorization safety data for the Pfizer-BioNTech coronavirus disease 2019 vaccination among children ages 5 to 11 years are available, particularly adverse event myocarditis, which has been detected in adolescents and young adults. We describe events observed during first 4 months of United States program this age group.We analyzed from 3 monitoring systems: v-safe, a voluntary smartphone-based system that monitors reactions health effects; Vaccine Adverse Events Reporting...
As of February 20, 2022, only BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine has been authorized for use in persons aged 12-17 years the United States (1). The Food and Drug Administration (FDA) amended Emergency Use Authorization (EUA) Pfizer-BioNTech on December 9, 2021, to authorize a homologous* booster dose 16-17 ≥6 months after receipt 2 On January 3, authorization was expanded include 12-15 years, all ≥12 interval between shortened ≥5 To characterize safety doses among (adolescents), CDC...
Abstract Background Gonorrhea is the second most commonly reported notifiable condition in United States. Infrequently, Neisseria gonorrhoeae can cause disseminated gonococcal infection (DGI). Eculizumab, a monoclonal antibody, inhibits terminal complement activation, which impairs ability of immune system to respond effectively infections. This series describes cases N. among patients receiving eculizumab. Methods Pre- and postmarketing safety reports eculizumab worldwide were obtained from...
Background: Chemsex is the intentional use of drugs to enhance sexual activity. drug among men who have sex with (MSM) associated behaviors that increase sexually transmitted infection (STI) risks and adverse mental health outcomes. However, published data are largely based on MSM recruited from STI clinics. There limited about chemsex national samples in United States. Using American Men's Internet Survey (AMIS), we assessed prevalence correlates active Methods: We used 2017 2020 AMIS...
We assessed spatial disparities in the distribution of Toxic Release Inventory (TRI) facilities Charleston, SC.We used methods and regression to assess burden study area at block census-tract levels by race/ethnicity socioeconomic status (SES).Results revealed an inverse relationship between distance TRI SES levels. Results analyses showed a positive association presence high percentage non-White negative number SES.There are Charleston level SES. Additional research is needed understand...
The ongoing U.S. opioid crisis has resulted in an increase drug overdose deaths and acute hepatitis C virus (HCV) infections, with young persons (who might be eligible organ donors) most affected.*,† In 2013, the Public Health Service released a revised guideline to reduce risk for unintended transplantation-associated B (HBV), HCV, human immunodeficiency (HIV) transmission (1). describes criteria categorize donors at increased (increased [IRDs]) transmitting these viruses recipients It also...
The Advisory Committee on Immunization Practices (ACIP) recommends that all persons aged ≥5 years receive 1 booster dose of a COVID-19 vaccine after completion their primary series.* On March 29, 2022, the Food and Drug Administration (FDA) authorized second mRNA ≥4 months receipt first for adults ≥50 ≥12 with moderate to severe immunocompromise (1,2). To characterize safety among years, CDC reviewed adverse events health impact assessments reported v-safe Vaccine Adverse Event Reporting...
In Spring 2021, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 (Alpha) became the predominant variant in United States. Research suggests that Alpha has increased transmissibility compared with non-Alpha lineages. We estimated household secondary infection risk (SIR), assessed characteristics associated transmission, and symptoms of persons infections.We followed households SARS-CoV-2 for weeks San Diego County metropolitan Denver, January to April 2021. collected...
Neisseria gonorrhoeae infection (gonorrhoea) is a global public health challenge, causing substantial sexual and reproductive consequences, such as infertility, pregnancy complications increased acquisition or transmission of HIV. There an urgency to controlling gonorrhoea because increasing antimicrobial resistance ceftriaxone, the last remaining treatment option, potential for become untreatable. No licensed gonococcal vaccine available. Mounting observational evidence suggests that N....
The 2022 mpox outbreak in the United States disproportionately affected gay, bisexual, and other men who have sex with (GBMSM). Uptake of testing may be related to symptomology, sociodemographic characteristics, behavioral characteristics. This study aimed describe suspected symptoms uptake among a sample GBMSM recruited via internet August 2022. We conducted rapid internet-based survey from 5 15, 2022, cisgender 15 years older had previously participated 2021 American Men's Internet Survey....
Background Extragenital gonorrhea (GC) and chlamydia (CT) are usually asymptomatic only detected through screening. Ceftriaxone plus azithromycin is the recommended GC treatment; monotherapy (azithromycin or doxycycline) for CT. In urethral CT-positive/urethral GC-negative persons who not screened extragenitally, CT can lead to undertreatment may foster development of gonococcal antimicrobial resistance. We assessed extragenital positivity among men have sex with (MSM) attending sexually...
Abstract Observational studies demonstrated 30–40% effectiveness of OMV meningococcal serogroup-B vaccines against gonorrhea. To explore whether healthy vaccinee bias influenced such findings, we examined MenB-FHbp, a non-OMV vaccine that is not protective MenB-FHbp was ineffective Healthy likely did confound earlier vaccines.
Community engagement remains a primary objective of public health practice. While this approach has been adopted with success in response to many community issues, it is rarely chemical disaster response. Empirical research suggests that management disasters focuses on the emergency almost no for long-term recovery. Graniteville, an unincorporated and medically underserved South Carolina was site one largest chlorine exposures by general US population. Following immediate response, we sought...
Recent research has presented evidence that men who have sex with (MSM) bear a disproportionate burden of HIV and are at increased risk for in sub-Saharan Africa (SSA). However, many countries SSA failed to address the needs MSM national HIV/AIDS programmes. Furthermore, face structural barriers prevention care, most significant which include laws criminalise male-to-male sexual contact facilitate stigma discrimination. This turn increases vulnerability acquiring presents prevention,...